These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
763 related articles for article (PubMed ID: 26984188)
1. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging. Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M; Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188 [TBL] [Abstract][Full Text] [Related]
2. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease. Hamelin L; Lagarde J; Dorothée G; Potier MC; Corlier F; Kuhnast B; Caillé F; Dubois B; Fillon L; Chupin M; Bottlaender M; Sarazin M Brain; 2018 Jun; 141(6):1855-1870. PubMed ID: 29608645 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease. Fan Z; Okello AA; Brooks DJ; Edison P Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952 [TBL] [Abstract][Full Text] [Related]
4. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189 [TBL] [Abstract][Full Text] [Related]
5. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Rabinovici GD; Furst AJ; Alkalay A; Racine CA; O'Neil JP; Janabi M; Baker SL; Agarwal N; Bonasera SJ; Mormino EC; Weiner MW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ Brain; 2010 Feb; 133(Pt 2):512-28. PubMed ID: 20080878 [TBL] [Abstract][Full Text] [Related]
6. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. Kreisl WC; Lyoo CH; McGwier M; Snow J; Jenko KJ; Kimura N; Corona W; Morse CL; Zoghbi SS; Pike VW; McMahon FJ; Turner RS; Innis RB; Brain; 2013 Jul; 136(Pt 7):2228-38. PubMed ID: 23775979 [TBL] [Abstract][Full Text] [Related]
9. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease. Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969 [TBL] [Abstract][Full Text] [Related]
10. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Barthel H; Gertz HJ; Dresel S; Peters O; Bartenstein P; Buerger K; Hiemeyer F; Wittemer-Rump SM; Seibyl J; Reininger C; Sabri O; Lancet Neurol; 2011 May; 10(5):424-35. PubMed ID: 21481640 [TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease. Kadir A; Marutle A; Gonzalez D; Schöll M; Almkvist O; Mousavi M; Mustafiz T; Darreh-Shori T; Nennesmo I; Nordberg A Brain; 2011 Jan; 134(Pt 1):301-17. PubMed ID: 21149866 [TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766 [TBL] [Abstract][Full Text] [Related]
13. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812 [TBL] [Abstract][Full Text] [Related]
14. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients. Golla SS; Boellaard R; Oikonen V; Hoffmann A; van Berckel BN; Windhorst AD; Virta J; Haaparanta-Solin M; Luoto P; Savisto N; Solin O; Valencia R; Thiele A; Eriksson J; Schuit RC; Lammertsma AA; Rinne JO J Cereb Blood Flow Metab; 2015 May; 35(5):766-72. PubMed ID: 25649991 [TBL] [Abstract][Full Text] [Related]
15. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Villeneuve S; Rabinovici GD; Cohn-Sheehy BI; Madison C; Ayakta N; Ghosh PM; La Joie R; Arthur-Bentil SK; Vogel JW; Marks SM; Lehmann M; Rosen HJ; Reed B; Olichney J; Boxer AL; Miller BL; Borys E; Jin LW; Huang EJ; Grinberg LT; DeCarli C; Seeley WW; Jagust W Brain; 2015 Jul; 138(Pt 7):2020-33. PubMed ID: 25953778 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Murray ME; Lowe VJ; Graff-Radford NR; Liesinger AM; Cannon A; Przybelski SA; Rawal B; Parisi JE; Petersen RC; Kantarci K; Ross OA; Duara R; Knopman DS; Jack CR; Dickson DW Brain; 2015 May; 138(Pt 5):1370-81. PubMed ID: 25805643 [TBL] [Abstract][Full Text] [Related]
17. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology. Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517 [TBL] [Abstract][Full Text] [Related]
18. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study. Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912 [TBL] [Abstract][Full Text] [Related]
19. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy. Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833 [TBL] [Abstract][Full Text] [Related]